Literature DB >> 31539678

Cyclothymic temperament: Associations with ADHD, other psychopathology, and medical morbidity in the general population.

Vigdis Elin Giaever Syrstad1, Ketil Joachim Oedegaard2, Ole Bernt Fasmer2, Anne Halmoy3, Jan Haavik4, Steven Dilsaver5, Rolf Gjestad6.   

Abstract

BACKGROUND: Cyclothymic temperament (CT) is an affective disposition often preceding bipolar disorder (BD), and is the most common affective temperament in patients with BD. In depressed patients, CT is a predictor for developing a bipolar course. In a clinical sample of adults with BD and attention deficit hyperactivity disorder (ADHD), CT was associated with higher loads of psychiatric symptoms, somatic comorbidity, impairment, and higher morbidity among first-degree relatives. We aimed to investigate the morbidity and occupational functioning of persons with CT in the general population.
METHODS: Randomly recruited Norwegian adults (n = 721) were assessed with a 21-item cyclothymic subscale from the TEMPS Autoquestionnaire. Self-reported data were collected on psychiatric symptoms, comorbidity, educational and occupational level, and known family morbidity.
RESULTS: Thirteen percent had CT associated with an increased prevalence of ADHD, BD, high scores on the Mood Disorder Questionnaire (MDQ), and childhood and adulthood ADHD symptoms. CT was found in 75% (p < .001) of the bipolar participants, and in 68% (p < .001) of those with a positive MDQ score. CT was associated with more anxiety/depression, substance and alcohol problems, lower educational and occupational levels, and having a first-degree relative with anxiety/depression, alcohol problems, ADHD, and BD. LIMITATIONS: The CT subscale alone might include overlapping features with cyclothymic, anxious, irritable, and depressed temperaments, thus increasing the prevalence estimate of CT.
CONCLUSIONS: CT is a strong predictor of occupational failure and associated with more psychiatric impairment in the participants and their families. CT should be assessed in both mood disorder and ADHD patients.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  ADHD; Bipolar disorder; Comorbidity; Cyclothymic temperament; General population; Temperament Evaluation of Memphis, Pisa, Paris and San Diego Autoquestionnaire (TEMPS-A)

Mesh:

Year:  2019        PMID: 31539678     DOI: 10.1016/j.jad.2019.08.047

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  Enduring effect of abuse: Childhood maltreatment links to altered theory of mind network among adults.

Authors:  Yajing Pang; Shanshan Zhao; Zhihui Li; Nan Li; Jiarui Yu; Rui Zhang; Fengmei Lu; Heng Chen; Fengchun Wu; Wei Zheng; Jingjing Gao; Yongfeng Yang; Huawang Wu; Jiaojian Wang
Journal:  Hum Brain Mapp       Date:  2022-01-28       Impact factor: 5.038

2.  Accurate Identification of ADHD among Adults Using Real-Time Activity Data.

Authors:  Amandeep Kaur; Karanjeet Singh Kahlon
Journal:  Brain Sci       Date:  2022-06-26

3.  Objective assessment of motor activity in a clinical sample of adults with attention-deficit/hyperactivity disorder and/or cyclothymic temperament.

Authors:  Vigdis Elin Giaever Syrstad; Kristin Mjeldheim; Wenche Førland; Petter Jakobsen; Rolf Gjestad; Jan Øystein Berle; Kathleen Ries Merikangas; Ketil Joachim Oedegaard; Ole Bernt Fasmer
Journal:  BMC Psychiatry       Date:  2022-09-14       Impact factor: 4.144

4.  Korean Validation of the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire.

Authors:  Hyeona Yu; Joohyun Yoon; Chan Woo Lee; Ji Yoon Park; Yoonjeong Jang; Yun Seong Park; Hyun A Ryoo; Nayoung Cho; Sunghee Oh; Won Kim; Jong-Min Woo; Hyo Shin Kang; Tae Hyon Ha; Woojae Myung
Journal:  Psychiatry Investig       Date:  2022-09-22       Impact factor: 3.202

5.  Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD.

Authors:  Giulio Emilio Brancati; Margherita Barbuti; Elisa Schiavi; Paola Colombini; Martina Moriconi; Alessandro Pallucchini; Marco Maiello; Giulia Menculini; Giulio Perugi
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.